Evidence map›Paper›PMID 42623176›Full record

ArticleJMIR AI2026

Augmenting Head and Neck Multidisciplinary Tumor Board Recommendations With Locally Run Large Language Models: Prospective Evaluation of Real-World Implementation.

Christoph Raphael Buhr, Lukas Müller, Daniel Pinto Dos Santos, Daniel Thiem, Jean-Jacques Ponciano, Maximilian Krüger, Karoline O'Brien, Justus Kaufmann, Hildegard Nolte, Martin Gartenschläeger and 7 more

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Christoph Raphael BuhrDepartment of Otorhinolaryngology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, Mainz, Germany, 49 6131 17 7362.ORCID http://orcid.org/0000-0002-9551-2310
Lukas MüllerDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-8626-4044
Daniel Pinto Dos SantosDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-4785-6394
Daniel ThiemDepartment of Oral and Maxillofacial Surgery-Plastic Surgery, University Medical Center Mainz of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-4081-1487
Jean-Jacques PoncianoDepartment of Otorhinolaryngology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, Mainz, Germany, 49 6131 17 7362.ORCID http://orcid.org/0000-0001-8950-5723
Maximilian KrügerDepartment of Oral and Maxillofacial Surgery-Plastic Surgery, University Medical Center Mainz of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Karoline O'BrienDepartment of Otorhinolaryngology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, Mainz, Germany, 49 6131 17 7362.ORCID http://orcid.org/0000-0002-7444-710X
Justus KaufmannDepartment of Radiotherapy and Oncology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-0189-3499
Hildegard NolteDepartment of Hematology & Medical Oncology, University Medical Center Mainz of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Martin GartenschläegerDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-4737-9305
Stefanie ZimmerInstitute of Pathology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Sebastian AltmannDepartment Neuroradiology, University Medical Center Mainz of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Andrew BlaikieUniversity of St Andrews, School of Medicine, St Andrews, United Kingdom.ORCID http://orcid.org/0000-0001-7913-6872
Christian RuckesInterdisciplinary Center for Clinical Trials (IZKS), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Christoph MatthiasDepartment of Otorhinolaryngology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, Mainz, Germany, 49 6131 17 7362.ORCID http://orcid.org/0000-0002-7569-2393
Sebastian KuhnInstitute for Digital Medicine Philipps-University Marburg and University Hospital of Giessen and Marburg, Marburg, Marburg, Germany.ORCID http://orcid.org/0000-0002-8031-2973
Jonas EckrichDepartment of Otorhinolaryngology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, Mainz, Germany, 49 6131 17 7362.ORCID http://orcid.org/0000-0001-5498-4031

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multidisciplinary tumor boards (MDTs) constitute the foundation of modern tumor therapy. Large language models (LLMs) are widely discussed for optimizing their recommendations. Objective: This is the first prospective feasibility study evaluating the implementation of locally run LLMs on real-world cases within a regular head and neck MDT. Methods: Seventeen patients participated in the study. The MDT cases were processed by 2 different local LLMs (gemma-3-12b and gpt-oss-20b) to obtain treatment recommendations. The MDT conferred as usual. After the decision was made, the MDT was presented with the LLMs' recommendations. If deemed to be beneficial, the MDT's recommendation was adjusted. The MDT members rated the LLMs' responses inter alia, for medical adequacy on a 6-point Likert scale. In addition, a tabular comparison of the MDT's and LLMs' recommendations was carried out. Results: In one case, 6% (1/17, 95% CI 0%-29%), the LLM was able to substantially improve the MDT recommendation by underscoring a follow-up examination that had not yet been performed. Concordance regarding the curative or palliative therapy regimen reached 94% (16/17, 95% CI 71%-100%); for gemma-3-12b and 59% (10/17, 95% CI 33%-82%) for gpt-oss-20b. Gemma-3-12b stated the same first-line therapy regimen as the MDT as first-line in 35% (6/17, 95% CI 14%-62%) of cases, and gpt-oss-20b in 41% (7/17, 95% CI 18%-67%) of cases. In 59% (10/17, 95% CI 33%-82%) of patients, gemma-3-12b stated the MDT's first-line therapy regimen, albeit with a different priority, while for gpt-oss-20b, it was 41% (7/17, 95% CI 18%-67%) of patients. Medical adequacy, as rated by the MDT members, revealed a median of 5 (IQR 2-5) for gemma-3-12b and 4 (IQR 3-5) for gpt-oss-20b. MDT members stated potentially hazardous information in 27% (25/93, 95% CI 18%-37%) of ratings for gemma-3-12b and 17% (14/83, 95% CI 9%-26%) of ratings for gpt-oss-20b. Conclusions: Locally run LLMs improved the MDT recommendation in 1 case and were primarily useful for identifying potentially relevant missing information in other cases, underscoring that they cannot replace MDTs. However, their observed benefit suggests that more advanced local models may offer safe, rapid, and cost-effective support for MDT decision-making. The study should be seen as an exploratory setting focusing on practical insights rather than benchmarking its clinical impact. Accordingly, the data demonstrate that the integration of LLMs in today's MDT workflow is feasible and may benefit the quality of decision-making in specific cases.

Indexed as

AIchatbotdigital healthhead and necklanguage modellarge language modelsLLMORLotorhinolaryngology

Identifiers

PMID42623176
PMCPMC13492482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.